Resultado de búsqueda
Hace 3 días · George III. George III (George William Frederick; 4 June 1738 – 29 January 1820) was King of Great Britain and Ireland from 25 October 1760 until his death in 1820. The Acts of Union 1800 unified Great Britain and Ireland into the United Kingdom of Great Britain and Ireland, with George as its king. He was concurrently Duke and Prince-elector ...
- 25 October 1760 – 29 January 1820
- Princess Augusta of Saxe-Gotha
4 de abr. de 2024 · Casada el 24 de abril 1880, Windsor Castle, con Alfons von Pawel-Rammingen, Freiherr von Pawel-Rammingen, nacido en 1843, fallecido en 1932, 89 años con Victoria Georgina Beatrice Maud Anne 1881-1881 20 días
19 de dic. de 2019 · "Von-Pawel-Rammingen Stiftung" is a company located in Germany, 10557 Berlin at Alt-Moabit 2. "Von-Pawel-Rammingen Stiftung" has an ACTIVE entity status and a LAPSED LEI code. The Legal Entity Identifier code of "Von-Pawel-Rammingen Stiftung" is 391200Y9HIEVFL2TSG97 .
2 de abr. de 2024 · The increasing prevalence of antimicrobial resistance against zoonotic bacteria, including Streptococcus (S.) suis, highlights the need for new therapeutical strategies, including the repositioning of drugs. In this study, susceptibilities of bacterial isolates were tested toward ten different 3-amidinophenyalanine (Phe(3-Am)) derivatives via determination of minimum inhibitory concentration ...
7 de abr. de 2024 · Daughter of Joseph, Herzog zu Sachsen-Altenburg and Duchess Amelia of Württemberg Wife of George V, King of Hanover Mother of Ernst August II, Kronprinz von Hannover (Crown Prince); Friederike Sophie Marie Henrietta Amelia Theresa of Hanover, Peincess, Freifrau von Pawel-Rammingen and Marie Ernestine Josephine Adolphine Henrietta Theresa Elizabeth Alexandrina Prinzessin von Hannover und ...
2 de abr. de 2024 · Z-LVG-CHN2: a Protein synthesis inhibitors Drug, Initially developed by Ferring Pharmaceuticals, Inc., Mechanism: Protein synthesis inhibitors.
22 de abr. de 2024 · Abstract. Introduction: The transplantation of highly sensitized patients remains a major obstacle. Immunized patients wait longer for a transplant if not prioritized, and if transplanted, their transplant outcome is worse. Case Presentation: We report a successful AB0- and HLA-incompatible living donor kidney transplantation in a 35-year-old female patient with systemic lupus erythematosus ...
